Chia Tai Enterprises International Limited (HKG:3839)
Hong Kong · Delayed Price · Currency is HKD 6.83
-0.04 (-0.58%)
Apr 2, 2026, 4:08 PM HKT
HKG:3839 Revenue
In the year 2025, Chia Tai Enterprises International had annual revenue of $535.91M USD with 74.14% growth. Chia Tai Enterprises International had revenue of $105.38M in the quarter ending December 31, 2025, a decrease of -23.19%.
Revenue
$535.91M
Revenue Growth
+74.14%
P/S Ratio
0.42
Revenue / Employee
$595.46K
Employees
900
Market Cap
1.74B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 535.91M | 228.17M | 74.14% |
| Dec 31, 2024 | 307.75M | 133.77M | 76.89% |
| Dec 31, 2023 | 173.98M | 14.74M | 9.26% |
| Dec 31, 2022 | 159.24M | 16.83M | 11.82% |
| Dec 31, 2021 | 142.41M | 48.83M | 52.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.93B |
| Essex Bio-Technology | 1.81B |
| Jacobson Pharma Corporation | 1.53B |
| Dawnrays Pharmaceutical (Holdings) | 1.37B |
| Golden Throat Holdings Group Company | 1.05B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |
| JBM (Healthcare) | 812.98M |
| Hua Medicine (Shanghai) | 548.54M |